Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-07

Clinical Trial Update: Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome

View source ↗

Summary

A completed study evaluating whether meconium concentrations of buprenorphine and methadone can predict outcomes in neonatal abstinence syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methadone (methadone)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: University Hospital, Caen | Conditions: Neonatal Abstinence Syndrome | Status: COMPLETED